相似文献
1
Methylene blue is not a pure vasoconstrictor drug.
Ann Card Anaesth. 2016 Apr-Jun;19(2):340-1. doi: 10.4103/0971-9784.179593.
2
Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation.
J Cardiothorac Vasc Anesth. 2010 Jun;24(3):463-6. doi: 10.1053/j.jvca.2008.07.015. Epub 2008 Oct 4.
3
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.
J Cardiothorac Vasc Anesth. 2019 May;33(5):1310-1314. doi: 10.1053/j.jvca.2018.11.025. Epub 2018 Nov 24.
4
Intravital Microscopy Evidence That Methylene Blue Should Be a Vasopressor-Sparing Agent in Sepsis Vasoplegia.
Braz J Cardiovasc Surg. 2024 Apr 3;39(3):e20230066. doi: 10.21470/1678-9741-2023-0066.
5
Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
A A Case Rep. 2015 Oct 15;5(8):127-30. doi: 10.1213/XAA.0000000000000190.
6
Methylene blue treatment for vasoplegia and resultant isoelectric processed EEG (bispectral index).
J Clin Anesth. 2012 Sep;24(6):511-3. doi: 10.1016/j.jclinane.2011.09.009.
7
A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.
BMJ Case Rep. 2015 Jul 6;2015:bcr2015210229. doi: 10.1136/bcr-2015-210229.
8
Vasoplegic syndrome--the role of methylene blue.
Eur J Cardiothorac Surg. 2005 Nov;28(5):705-10. doi: 10.1016/j.ejcts.2005.07.011. Epub 2005 Sep 6.
9
Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
Semin Cardiothorac Vasc Anesth. 2010 Sep;14(3):186-9. doi: 10.1177/1089253210379271.
10
A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Tex Heart Inst J. 2015 Oct 1;42(5):491-4. doi: 10.14503/THIJ-14-4470. eCollection 2015 Oct.
本文引用的文献
1
Pharmacologic agents for acute hemodynamic instability: recent advances in the management of perioperative shock- a systematic review.
Ann Card Anaesth. 2015 Oct-Dec;18(4):543-54. doi: 10.4103/0971-9784.166464.
2
Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.
Rev Bras Cir Cardiovasc. 2015 Jan-Mar;30(1):84-92. doi: 10.5935/1678-9741.20140115.
3
Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
Rev Bras Cir Cardiovasc. 2009 Jul-Sep;24(3):279-88. doi: 10.1590/s0102-76382009000400005.
4
Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Mol Pharmacol. 2006 Mar;69(3):983-90. doi: 10.1124/mol.105.015479. Epub 2005 Dec 2.
Zotero 插件